SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (AMEX:INO) today reported financial results for the three and nine months ended September 30, 2007. Total revenue for the three and nine months ended September 30, 2007 was $486,511 and $1,485,990, respectively, as compared to $575,829 and $1,936,512, respectively, for the same periods in 2006. Revenue consisted of license fees, milestone payments, revenue recognized from collaborative research and development arrangements and grants.
